CORE Biomedicine
Developing the next generation of precision medicines by going beyond genomics.
$21MSeries A
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Developing the next generation of precision medicines by going beyond genomics.
Develops antibody-based therapies for autoimmune diseases and cancer
Develops next-generation cell therapies for oncology and immunology
Pitching Elikon Venture? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room